|
|
Volumn 1, Issue 3, 2011, Pages 329-333
|
|
How is agitation and restlessness managed in the last 24 h of life in patients whose care is supported by the Liverpool care pathway for the dying patient?
a a a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HALOPERIDOL;
HYPNOTIC SEDATIVE AGENT;
LEVOMEPROMAZINE;
MIDAZOLAM;
NEUROLEPTIC AGENT;
AGED;
CLINICAL PATHWAY;
COHORT ANALYSIS;
FEMALE;
HOSPITAL;
HUMAN;
MALE;
PATIENT CARE;
PROCEDURES;
PSYCHOMOTOR AGITATION;
RETROSPECTIVE STUDY;
SUBCUTANEOUS DRUG ADMINISTRATION;
TERMINAL CARE;
TERMINALLY ILL PATIENT;
VERY ELDERLY;
AGED;
AGED, 80 AND OVER;
ANTIPSYCHOTIC AGENTS;
COHORT STUDIES;
CRITICAL PATHWAYS;
FEMALE;
HALOPERIDOL;
HOSPITALS;
HUMANS;
HYPNOTICS AND SEDATIVES;
INFUSIONS, SUBCUTANEOUS;
MALE;
METHOTRIMEPRAZINE;
MIDAZOLAM;
PATIENT-CENTERED CARE;
PSYCHOMOTOR AGITATION;
RETROSPECTIVE STUDIES;
TERMINAL CARE;
TERMINALLY ILL;
|
|
EID: 84995550167
PISSN: None
EISSN: 20454368
Source Type: Journal
DOI: 10.1136/bmjspcare-2011-000075 Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|